Recombinant Human SLAM Family Member 7/SLAMF7/CD319/CRACC (C-6His-Avi) Biotinylated
Recombinant Human SLAM Family Member 7/SLAMF7/CD319/CRACC (C-6His-Avi) Biotinylated supplied by Elabscience with collaborator-provided technical specifications. Read more ›
["35-55 kDa"]Product Description
SLAMF7 is the stated recombinant protein target for this Elabscience product. The listing uses collaborator-supplied specifications to support research-use-only protein selection through ABMIUM.
Protein profile: reactive species/source: Human; expression system: HEK293 Cells; physical form: Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.<br/>Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.<br/>Please refer to the specific buffer information in the printed manual.; tag: Human ,SLAMF7 ,Recombinant Proteins; predicted molecular weight: 25.2 kDa.
Quality and formulation: purity: > 95 % as determined by reducing SDS-PAGE.; endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method..
Sequence coverage: 25.2 kDa.
Database references: UniProt: Q9NQ25 | NCBI Gene: 57823 | Gene symbol: SLAMF7.
Research Use Only.
Key Facts
| Target | SLAMF7 |
| Also known as | UNQ, PRO, SLAM, SLAMF7, 19A, CD319, CRACC, CS1, 19A24 protein, CD 319, CD2 like receptor activating cytotoxic cells, CD2 subset 1, CD2-Like Receptor-Activating Cytotoxic Cells, CD319 antigen, Membrane protein FOAP 12, Membrane Protein FOAP-12, Novel Ly9, Novel LY9 (lymphocyte antigen 9) like protein, Protein 19A, SLAM family member 7, SLAM7, SLAMF 7, UNQ576, PRO1138, CS1, CD319, CRACC, CS1, Novel Ly9 |
| Species reactivity | Human |
| Purity | > 95 % as determined by reducing SDS-PAGE. |
| Form / buffer | Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4. Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
| Shelf life | 12 months |
| Research area | immunology |
| BIOACTIVITY | BINDING | CELL-BASED | IN VIVO | ELISA CAPTURE | |
|---|---|---|---|---|---|
| Human |
Specifications
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.